Thrombocytopenia, prolongation of prothrombin time, and activated partial thromboplastin time were found, as well as erythrocyte abnormalities in the blood smear and a decrease in CGMH in the VLoxo group (20). The gene discussed is F2; the disease is Thrombocytopenia.